Company profile for Aspen Neuroscience

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Summit for Stem Cell was founded in 2011 because of a desire from Parkinson patients to fund a stem cell-based therapy for their disease. Summit started as a small group of friends raising money for a cause they believed in and grew into a large organization with supporters all over the world. Summit funded the work in Jeanne Loring’s lab at The Scripps Research Institute to develop an autologous neuron replacement program. ...
Summit for Stem Cell was founded in 2011 because of a desire from Parkinson patients to fund a stem cell-based therapy for their disease. Summit started as a small group of friends raising money for a cause they believed in and grew into a large organization with supporters all over the world. Summit funded the work in Jeanne Loring’s lab at The Scripps Research Institute to develop an autologous neuron replacement program. After years of successfully supporting and promoting this brilliant body of science, Summit helped found Aspen Neuroscience, Inc. in late 2018. The iPSC-based therapy has been transferred to Aspen Neuroscience, Inc.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
10835 Road to the Cure, Ste. 100, San Diego, CA 92121
Telephone
Telephone
+1 (858) 263-1222
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/aspen-enriches-parkinsons-cell-therapy-trial-kite-backed-115m-series-c

FIERCE BIOTECH
20 Nov 2025

https://www.prnewswire.com/news-releases/aspen-neuroscience-initiates-cohort-3-in-aspiro-phase-12a-trial-highlighting-commercial-formulation-of-anpd001-and-its-transformative-potential-for-parkinsons-disease-302566431.html

PR NEWSWIRE
25 Sep 2025

https://www.prnewswire.com/news-releases/aspen-neuroscience-advances-the-automated-production-of-personalized-autologous-cell-therapy-for-parkinsons-disease-302345561.html

PR NEWSWIRE
10 Jan 2025

https://www.contractpharma.com/breaking-news/mytos-aspen-partner-to-automate-parkinsons-disease-cell-therapy-manufacturing/

CONTRACTPHARMA
08 Jan 2025

https://www.prnewswire.com/news-releases/aspen-neuroscience-to-showcase-advances-in-autologous-cell-therapy-development-at-2024-cell--gene-meeting-on-the-mesa-302268525.html

PR NEWSWIRE
07 Oct 2024
Aspen Neuroscience levels up in-house cell therapy production
Aspen Neuroscience levels up in-house cell therapy production

02 Oct 2024

// Fraiser Kansteiner FIERCE PHARMA

https://www.fiercepharma.com/pharma/parkinsons-cell-therapy-trial-advances-aspen-neuroscience-unveils-22000-sq-ft-expanded-house

Fraiser Kansteiner FIERCE PHARMA
02 Oct 2024

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty